Teva Pharmaceutical Industries, Ltd.: all 671 studies
Page 2 of 7. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent AsthmaCompletedNCT02031640Phase 3Results posted
- A Multicenter Assessment of LBR-101 in High Frequency Episodic MigraineCompletedNCT02025556Phase 2Results posted
- Assessment of LBR-101 In Chronic MigraineCompletedNCT02021773Phase 2Results posted
- A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic KeratosisCompletedNCT01962987Phase 3Results posted
- Open-Label, Extension Study to Evaluate the Safety of Hydrocodone Bitartrate Extended-Release TabletsCompletedNCT01922739Phase 3Results posted
- Efficacy and Safety Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane (HFA) in Pediatric PatientsCompletedNCT01899144Phase 2Results posted
- Alternatives for Reducing Chorea in Huntington DiseaseCompletedNCT01897896Phase 3Results posted
- Safety and Tolerability of Glatiramer AcetateCompletedNCT01874145Phase 3Results posted
- Open-Label Assessment of the Albuterol Spiromax® Dry Powder Inhaler (DPI)CompletedNCT01857323Phase 3Results posted
- Clinical Equivalence Study of Mometasone Nasal SprayCompletedNCT01850823Phase 3Results posted
- Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®CompletedNCT01803555Phase 3Results posted
- First Time Use of SD-809 in Huntington DiseaseCompletedNCT01795859Phase 3Results posted
- Efficacy of Albuterol SPIROMAX® in Adult and Adolescent Patients With Exercise-Induced Bronchoconstriction (EIB)CompletedNCT01791972Phase 3Results posted
- Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets for Moderate to Severe Chronic Low Back PainCompletedNCT01789970Phase 3Results posted
- Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Allergic Rhinitis (PAR)CompletedNCT01783548Phase 3Results posted
- Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma SubjectsCompletedNCT01772368Phase 2Results posted
- Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State PharmacokineticsCompletedNCT01747629Phase 3Results posted
- Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's DiseaseCompletedNCT01723228Phase 4Results posted
- The Efficacy, Safety, and Tolerability of Laquinimod in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT01707992Phase 3Results posted
- Safety Study of Albuterol Spiromax® in Subjects With AsthmaCompletedNCT01698320Phase 3Results posted
- Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)CompletedNCT01697956Phase 3Results posted
- Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic KeratosisCompletedNCT01686152Phase 3Results posted
- A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab TreatmentCompletedNCT01596621Phase 3Results posted
- An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)TerminatedNCT01578785Phase 3Results posted
- A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma MedicationsCompletedNCT01576718Phase 2Results posted
- Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe AsthmaCompletedNCT01508936Phase 3Results posted
- A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing SteroidsCompletedNCT01479621Phase 2Results posted
- A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent AsthmaCompletedNCT01424813Phase 3Results posted
- A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy WomenCompletedNCT01388491Phase 2Results posted
- Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple MyelomaCompletedNCT01348919Phase 1/2Results posted
- Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted ConditionsCompletedNCT01344369Phase 1Results posted
- Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting ConditionsCompletedNCT01340625Phase 1Results posted
- Study to Determine the Maximum Tolerated Dose of the PARP Inhibitor CEP-9722 in Participants With Solid TumorsTerminatedNCT01311713Phase 1/2Results posted
- Study of an Investigational Nasal Aerosol or Placebo Nasal Aerosol in Children (Ages 6-11) With Seasonal AllergiesCompletedNCT01307319Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCompletedNCT01305408Phase 3Results posted
- Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic AsthmaTerminatedNCT01290887Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic AsthmaCompletedNCT01287039Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic AsthmaCompletedNCT01285323Phase 3Results posted
- Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle StudyCompletedNCT01282814Phase 1Results posted
- Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed ConditionsCompletedNCT01282801Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic AsthmaCompletedNCT01270464Phase 3Results posted
- 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting ConditionsCompletedNCT01260948Phase 1Results posted
- 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.CompletedNCT01260922Phase 1Results posted
- Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fasting ConditionsCompletedNCT01260896Phase 1Results posted
- A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy WomenCompletedNCT01252186Phase 2Results posted
- 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting ConditionsCompletedNCT01247285Phase 1Results posted
- 90 mg Fluoxetine Hydrochloride Capsules Under Fasting ConditionsCompletedNCT01247272Phase 1Results posted
- Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of TimeCompletedNCT01240863Phase 3Results posted
- A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus ErythematosusTerminatedNCT01240694Phase 3Results posted
- Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of TimeCompletedNCT01223365Phase 3Results posted
- A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed DosingTerminatedNCT01218009Phase 3Results posted
- Anastrozole 1 mg Tablets Under Fed ConditionsCompletedNCT01183390Phase 1Results posted
- Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting ConditionsCompletedNCT01182207Phase 1Results posted
- Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.CompletedNCT01182194Phase 1Results posted
- Anastrozole 1 mg Tablets Under Fasting ConditionsCompletedNCT01182181Phase 1Results posted
- Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fed ConditionsCompletedNCT01181726Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of PregnancyCompletedNCT01178125Phase 3Results posted
- Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) PatientsCompletedNCT01167426Phase 3Results posted
- Estradiol/Norethindrone Acetate Tablets, 1/0.5 mg Under Fasting ConditionsCompletedNCT01157182Phase 1Results posted
- Buprenorphine 8 mg Sublingual Tablets Under Fasting ConditionsCompletedNCT01157169Phase 1Results posted
- Tamsulosin Hydrochloride 0.4 mg Capsules Under Fed ConditionsCompletedNCT01149733Phase 1Results posted
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Fasting ConditionsCompletedNCT01149486Phase 1Results posted
- Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting ConditionsCompletedNCT01149473Phase 1Results posted
- Valacyclovir 1000 mg Tablet Under Fed ConditionsCompletedNCT01149460Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)CompletedNCT01135459Phase 2Results posted
- Study in Adult and Adolescent Subjects With PAR (Perennial Allergic Rhinitis)CompletedNCT01134705Phase 3Results posted
- Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Adult and Adolescent Subjects With Perennial Allergic Rhinitis (PAR)CompletedNCT01133626Phase 3Results posted
- Neugranin in Breast Cancer Participants Receiving Doxorubicin/DocetaxelCompletedNCT01126190Phase 3Results posted
- Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting ConditionsCompletedNCT01124175Phase 1Results posted
- Losartan 100 mg Tablets in Healthy Subjects Under Fasting ConditionsCompletedNCT01124162Phase 1Results posted
- TL011 in Severe, Active Rheumatoid Arthritis PatientsCompletedNCT01123070Phase 1Results posted
- Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderTerminatedNCT01121536Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)CompletedNCT01108341Phase 2Results posted
- Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT01088984Phase 1/2Results posted
- A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus NephritisCompletedNCT01085097Phase 2Results posted
- A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus ArthritisCompletedNCT01085084Phase 2Results posted
- Efficacy and Tolerability of Armodafinil in Adults With Excessive Sleepiness Associated With Shift Work DisorderCompletedNCT01080807Phase 4Results posted
- Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting ConditionsCompletedNCT01074463Phase 1Results posted
- Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting ConditionsCompletedNCT01074450Phase 1Results posted
- Study to Assess the Effect of Treatment With Bendamustine in Combination With Rituximab on QT Interval in Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL)CompletedNCT01073163Phase 3Results posted
- A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCompletedNCT01072929Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCompletedNCT01072630Phase 3Results posted
- A Study in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS) to Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate (GA) Injection 40 mg Administered Three Times a Week Compared to PlaceboCompletedNCT01067521Phase 3Results posted
- A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent AsthmaCompletedNCT01058863Phase 2Results posted
- Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's DiseaseCompletedNCT01049984Phase 4Results posted
- A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple SclerosisTerminatedNCT01047319Phase 3Results posted
- Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle StudyCompletedNCT01046253Phase 1Results posted
- Lansoprazole 30 mg DR Capsule Replicate Food StudyCompletedNCT01046084Phase 1Results posted
- Lansoprazole 30 mg DR Capsule Fasting StudyCompletedNCT01045967Phase 1Results posted
- Study in Adult and Adolescent Subjects With Seasonal Allergic Rhinitis (SAR)CompletedNCT01024608Phase 3Results posted
- Bioavailability of Metronidazole Vaginal Gel in Healthy SubjectsCompletedNCT01020877Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of DR-103 for the Prevention of PregnancyCompletedNCT00996580Phase 3Results posted
- Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant PatientsTerminatedNCT00991510Phase 4Results posted
- Comparison of a Needle-free Injection Method With a Needle-syringe Injection MethodCompletedNCT00990340Phase 4Results posted
- Long Term Safety and Efficacy Trial of Beclomethasone Dipropionate - Hydrofluoroalkane (BDP-HFA) 320 mcg in Allergic RhinitisCompletedNCT00988247Phase 3Results posted
- A Study To Evaluate the Long-Term Safety, Tolerability and Effect on Disease CourseTerminatedNCT00988052Phase 3Results posted
- Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain InjuryTerminatedNCT00983437Phase 3Results posted
- Clinical Trial to Assess Efficacy, Safety, and Tolerability of Rasagiline Mesylate 1 mg in Patients With Multiple System Atrophy of the Parkinsonian Subtype (MSA-P)CompletedNCT00977665Phase 2Results posted
- Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic KeratosisCompletedNCT00948428Phase 3Results posted
- Safety of New Formulation of Glatiramer AcetateCompletedNCT00947752Phase 3Results posted
← Teva Pharmaceutical Industries, Ltd. overview and focus areas